108 related articles for article (PubMed ID: 11364937)
1. HIV drug resistance and the other causes of treatment failure.
Schouten JT
STEP Perspect; 1997; 9(3):5-8. PubMed ID: 11364937
[TBL] [Abstract][Full Text] [Related]
2. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
3. Drug failure and HIV resistance create frustrating scenarios for clinicians.
Murphy MJ
Fac Notes (New Orleans La); 1998; 10(5):1-3. PubMed ID: 11365830
[TBL] [Abstract][Full Text] [Related]
4. Genotypic resistance tests for the clinical management of patients with primary HIV infection.
Narciso P; Lazzarin A
Scand J Infect Dis Suppl; 2003; 106():66-70. PubMed ID: 15000588
[TBL] [Abstract][Full Text] [Related]
5. HIV resistance testing proves its value.
Proj Inf Perspect; 1999 Sep; (28):14. PubMed ID: 11367356
[TBL] [Abstract][Full Text] [Related]
6. Viral resistance: how it may affect treatment options.
Biehler GV
Body Posit; 1998 Jun; 11(6):42-3. PubMed ID: 11365610
[TBL] [Abstract][Full Text] [Related]
7. Guidance offered in drug combination choices.
AIDS Alert; 1997 Dec; 12(12):135-7. PubMed ID: 11364831
[TBL] [Abstract][Full Text] [Related]
8. Resistance testing debate: does it make the grade?
Simmons P
Res Initiat Treat Action; 1999 Oct; 5(4):9-12. PubMed ID: 11366943
[TBL] [Abstract][Full Text] [Related]
9. Genotypic resistance tests for the management of structured therapeutic interruptions after multiple drug failure.
Montroni M; Monforte AD
Scand J Infect Dis Suppl; 2003; 106():79-81. PubMed ID: 15000591
[TBL] [Abstract][Full Text] [Related]
10. HIV-1 drug resistance assays in clinical management.
Martinez-Picado J; D'Aquila R
AIDS Clin Care; 1998 Nov; 10(11):81-5, 87-8. PubMed ID: 11365861
[TBL] [Abstract][Full Text] [Related]
11. Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
Prescrire Int; 2004 Aug; 13(72):144-50. PubMed ID: 15532140
[TBL] [Abstract][Full Text] [Related]
12. Adherence to combination antiretroviral therapy: synthesis of the literature and clinical implications.
Miller LG; Hays RD
AIDS Read; 2000 Mar; 10(3):177-85. PubMed ID: 10758022
[TBL] [Abstract][Full Text] [Related]
13. What you need to know about HIV resistance.
AIDS Alert; 1997 Oct; 12(10):suppl 1-2. PubMed ID: 11364721
[TBL] [Abstract][Full Text] [Related]
14. Replication capacity, biological phenotype, and drug resistance of HIV strains isolated from patients failing antiretroviral therapy.
Nicastri E; Sarmati L; d'Ettorre G; Palmisano L; Parisi SG; Uccella I; Rianda A; Concia E; Vullo V; Vella S; Andreoni M
J Med Virol; 2003 Jan; 69(1):1-6. PubMed ID: 12436471
[TBL] [Abstract][Full Text] [Related]
15. New questions about therapy. Boston AIDS Writers Group.
Surviv News (Atlanta Ga); 1998 May; ():19-20. PubMed ID: 11365366
[TBL] [Abstract][Full Text] [Related]
16. Genotypic resistance tests in the management of the HIV-infected patient at virological failure.
Aceti A; Carosi G
Scand J Infect Dis Suppl; 2003; 106():61-6. PubMed ID: 15000587
[TBL] [Abstract][Full Text] [Related]
17. Antiretrovirals for the heavily experienced patient: hefty plans to holidays.
Martinez LJ
Res Initiat Treat Action; 1999 Oct; 5(4):5-8. PubMed ID: 11366942
[TBL] [Abstract][Full Text] [Related]
18. Molecular biological assessment methods and understanding the course of the HIV infection.
Katzenstein TL
APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
[TBL] [Abstract][Full Text] [Related]
19. Your next nightmare: 28% of new HIV cases may be drug-resistant.
AIDS Alert; 1999 Dec; 14(12):133-7. PubMed ID: 11366987
[TBL] [Abstract][Full Text] [Related]
20. Impact of genotypic resistance testing on selection of salvage regimen in clinical practice.
Haupts S; Ledergerber B; Böni J; Schüpbach J; Kronenberg A; Opravil M; Flepp M; Speck RF; Grube C; Rentsch K; Weber R; Günthard HF;
Antivir Ther; 2003 Oct; 8(5):443-54. PubMed ID: 14640392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
